News
Ennui prevailed. Out of government-speak few, if any, new thoughts emerged. The headwinds against a practical approach for focal therapy for prostate cancer are challenging. Herein are the ...
The poster entitled “Immunomodulatory Potential of Human Dermal Fibroblast Spheroids in Psoriasis Therapy” can be viewed here (Fang et al., 2025).
Includes 40, 80, 120, and 160 mg TUS dose as a single agentIncludes those who failed prior therapy with venetoclaxIncludes those with mutated or unmutated FLT3, those who failed prior-HSCT ...
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell TherapyLONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings ...
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting Provided by Business Wire May 6, 2025, 11:00:00 AM ...
Contacts Kathleen Skarvan President and Chief Executive Officer [email protected] 952-758-9299 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results